Vaccines to prevent infectious diseases have saved millions of lives worldwide, yet there remains a need for new and improved vaccines against existing and emerging infections. Efforts to develop safe and effective vaccines increasingly involve the use of adjuvants—substances formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvant discovery and development play critical roles in NIAID vaccine development efforts.
Media Availability: NIH Awards Six Grants to Explore How Combination Adjuvants Improve Vaccines—April 4, 2016
Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant—Oct. 7, 2014
NIH Awards Seven New Vaccine Adjuvant Discovery Contracts—Sept. 29, 2014
NIH Begins Testing H7N9 Avian Influenza Vaccine Candidate: Possible Role For Adjuvants to Be Examined—Sept. 18, 2013
All Vaccine Research News Releases
News From NIAID-Supported Institutions
Last Updated April 04, 2016